SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • March 22nd, 2018 • AmpliPhi Biosciences Corp • Biological products, (no disgnostic substances) • New York
Contract Type FiledMarch 22nd, 2018 Company Industry JurisdictionThis Securities Purchase Agreement (this “Agreement”) is dated as of March 20, 2018, between AmpliPhi Biosciences Corporation, a Washington corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively the “Purchasers”).